Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
89.20    2.00 (2.29%)
Bid:
88.80
Ask:
89.30
Spread: 0.50 (0.563%)
Market Cap: £374.96m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading update

27 Jun 2022 07:00

RNS Number : 2115Q
PZ CUSSONS PLC
27 June 2022
Β 

27 June 2022

Β 

Trading update

Β 

Continued strategic progress and performance in line with expectations

Β 

PZ Cussons plc today issues a trading update for the year ended 31 May 2022.

Β 

Trading in the fourth quarter has continued to be in line with expectations. As such, we anticipate reporting Group revenue for the year of approximately Β£590 million, with full year like for like (LFL) revenue growth of 3% and Q4 LFL growth of 7%. Growth continues to be driven primarily by improvements in price/mix, with limited impact on volumes. Our expectations for FY22 Adjusted Profit Before Tax are unchanged.

Β 

We continue to see good revenue momentum on our Must Win Brands, which grew 4% in Q4. This sequential improvement reflects the ongoing benefit of marketing and executional focus, a normalising of the supply challenges for US Beauty, and a significantly lower rate of decline in Carex, as the demand for the Hand Hygiene category in the UK normalises following the COVID pandemic.

Β 

Childs Farm, which was acquired in March, has performed in line with expectations and our plans to develop the brand are progressing well.

Β 

Jonathan Myers, Chief Executive Officer, said:

Β 

"As we close our first full financial year under our new strategy,Β 'Building brands for life. Today and for future generations', I am pleased with the significant progress made in returning the business to sustainable, profitable revenue growth. With a new team in place, we have re-focused on the core job of building brands and have started to unlock value through dramatically reducing complexity in our business.

Β 

The trading environment continues to be challenging, with high input cost inflation and pressures on household budgets. We have plans in place to mitigate the impact of this, as we continue to deliver great value for consumers, whilst also investing behind more premium innovations. The recent introduction of our new portfolio brand, Cussons Creations, for the value-conscious consumer, alongside the re-launches of Sanctuary Spa and Imperial Leather, are good examples of such initiatives. They have been well received by customers and have allowed us to secure significant distribution gains.

We have great brands and great people and, whilst there is more to be done to deliver against our strategy, we remain excited by the long-term opportunities ahead of us."

Β 

PZ Cussons will report FY22 results and provide a FY23 outlook, along with its Q1 trading update, on 22nd September.

Β 

Contact details

Β 

Investors

Simon Whittington - IR and Corporate Development Director

+44 (0) 7711 372 928

Media

Tim Linacre / Guy Scarborough - Instinctif

+44 (0) 20 7457 2020

Β 

Notes to Editors

Β 

Unless otherwise stated, all references to revenue growth are on a like for like ('LFL') basis which adjusts for constant currency and excludes the impact of disposals (five:am) and acquisitions (Childs Farm).

Β 

Figures are unaudited and are still subject to review by the Group's auditors.

Β 

About PZ Cussons

Β 

PZ Cussons is a FTSE250 listed consumer goods business, headquartered in Manchester, UK. We employ over 3,000 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Imperial Leather, Original Source, Cussons Baby, Sanctuary Spa, St.Tropez, Morning Fresh and Premier. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

Β 

Β 

Cautionary note regarding forward-looking statements

Β 

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward looking statements contained within this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTPPUQWQUPPPPQ
Date   Source Headline
1st Jul 20145:30 pmRNSDirector/PDMR Shareholding
12th Jun 20147:00 amRNSTrading Update
10th Apr 20147:00 amRNSInterim Management Statement
31st Mar 201412:08 pmRNSDirector/PDMR Shareholding
14th Feb 20149:32 amRNSSale of Polish Home Care brands
12th Feb 20147:00 amRNSAppointment of a new Non-executive Director
6th Feb 20141:00 pmRNSSale of Polish Home Care brands
3rd Feb 20145:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20145:30 pmRNSDirector/PDMR Shareholding
21st Jan 20147:00 amRNSHalf Yearly Report
31st Dec 201312:30 pmRNSDirector/PDMR Shareholding
11th Dec 20137:00 amRNSTrading Update
19th Nov 20135:30 pmRNSHolding(s) in Company
1st Nov 20135:30 pmRNSHolding(s) in Company
29th Oct 20136:06 pmRNSHolding(s) in Company
30th Sep 20132:09 pmRNSDirector/PDMR Shareholding
25th Sep 20135:30 pmRNSResult of AGM
25th Sep 20137:00 amRNSInterim Management Statement
15th Aug 20135:30 pmRNSDirector/PDMR Shareholding
5th Aug 20135:30 pmRNSDirector/PDMR Shareholding
25th Jul 20135:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20137:00 amRNSFinal Results
2nd Jul 20137:00 amRNSAcquisition of Rafferty's Garden
1st Jul 20132:30 pmRNSDirector/PDMR Shareholding
13th Jun 20137:00 amRNSTrading Update
21st May 20137:00 amRNSPresentations to investors
26th Apr 20132:08 pmRNSHolding(s) in Company
11th Apr 20137:00 amRNSInterim Management Statement
2nd Apr 20139:53 amRNSDirector/PDMR Shareholding
28th Mar 20136:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20135:30 pmRNSDirector/PDMR Shareholding
20th Feb 20137:00 amRNSSALE OF POLISH HOME CARE BRANDS
29th Jan 20137:00 amRNSHalf Yearly Report
31st Dec 201211:13 amRNSDirector/PDMR Shareholding
6th Dec 20127:00 amRNSTrading Statement
30th Nov 20126:16 pmRNSAnnual Information Update
23rd Nov 20128:27 amRNSHolding(s) in Company
1st Oct 20122:53 pmRNSDirector/PDMR Shareholding
19th Sep 20125:30 pmRNSResult of AGM
19th Sep 20127:00 amRNSInterim Management Statement
28th Aug 20128:54 amRNSDirector/PDMR Shareholding
15th Aug 20125:00 pmRNSDirector/PDMR Shareholding
26th Jul 20121:25 pmRNSDirector/PDMR Shareholding
24th Jul 20127:00 amRNSFinal Results
2nd Jul 20127:00 amRNSPresentations to investors
29th Jun 201210:23 amRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSTrading Update
16th May 20126:30 pmRNSHolding(s) in Company
9th May 20126:30 pmRNSHolding(s) in Company
8th May 20126:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.